ARKRAY, Inc., a leading player in the medical technology industry, is headquartered in Japan and operates extensively across Asia, Europe, and North America. Founded in 1948, the company has established itself as a pioneer in diabetes care and diagnostic solutions, achieving significant milestones in innovation and product development. Specialising in blood glucose monitoring systems, urinalysis products, and other diagnostic tools, ARKRAY is renowned for its commitment to quality and precision. Their unique offerings, such as the GLUCOCARD series, are designed to enhance patient care and streamline clinical workflows. With a strong market position, ARKRAY continues to be recognised for its contributions to healthcare, making strides in improving the lives of individuals managing chronic conditions.
How does ARKRAY, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Other Non-Ferrous Metal Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ARKRAY, Inc.'s score of 13 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ARKRAY, Inc., headquartered in Japan, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. As a result, ARKRAY's climate commitments and initiatives remain unclear, and there is no information regarding any cascading data from parent or related organizations. Without specific emissions data or reduction initiatives, it is challenging to assess the company's environmental impact or commitment to sustainability within the industry context.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ARKRAY, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

